CanSino Biologics (康希诺) IPO: Valuation Attractive, Lilly Asia Doubling Up (Part 4)
CanSino Biologics started its book building today to raise up to USD 160 million to list in Hong Kong. In our previous insights (links provided...
812 Views
ECM Weekly (16 March 2019) - Embassy Office REIT, Tiger Brokers, Dongzheng Auto, Koolearn, CanSino
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
485 Views
CanSino Biologics (康希诺) IPO: Valuation Update (Part 3)
CanSino is a China-based biotechnology company with a focus on vaccine development. In our previous insight (link to Part 1 and Part 2), we have...
359 Views
CanSino Biologics (康希诺) IPO: Thoughts on Valuation (Part 2)
CanSino is a China-based biotechnology with a focus on vaccine development. In our previous insight (link here), we have discussed the CanSino's...
720 Views
ECM Weekly (17 November 2018) - Softbank Corp, Tongcheng-Elong, Junshi Bio, QSR, Sinochem Energy
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
790 Views